Judith de Vos: The Immune Composition of Thrombi in Ischemic Stroke
Judith de Vos, Research technician at Biomedical Engineering and Physics at Amsterdam UMC, shared a post on LinkedIn about a recent article her and her colleagues co-authored, published in RPTH, adding:
“Great to share that the paper; Correlation of Thrombus Immune Cell Composition and Clinical Outcome in Acute Ischemic Stroke: A MR CLEAN-NO IV sub-study by Yan Wang et al, was just published in Research and Practice in Thrombosis and Haemostasis.”
Title: Correlation of Thrombus Immune Cell Composition and Clinical Outcome in Acute
Ischemic Stroke: A MR CLEAN-NO IV sub-study
Authors: Yan Wang, Marc A. Franssen, Laura M. De Santis, Judith de Vos, Luna Molter, Willeke F. Westendorp, Rutger Koning, Charles B. Majoie, Diederik W.J. Dippel, Robert J. van Oostenbrugge, Heleen M.M. van Beusekom, Diederik van de Beek, Jonathan M. Coutinho, Inge A. Mulder
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy